A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

• Status: Completed
• Trial end date: 2009-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The study objective is to compare IOP and safety outcomes based on plug placement (upper or lower puncta).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mati Therapeutics Inc.
• Collaborator: QLT Inc.
• Treatments: Latanoprost

Criteria

Inclusion Criteria:

• Over 18 years

• Diagnosed with bilateral Open-Angle Glaucoma or Ocular Hypertension

Exclusion Criteria:

• Uncontrolled medical conditions

• Subjects who wear contact lenses

• Subjects requiring chronic topical artificial tears, lubricants, and /or requiring any other chronic topical medications